Psychological distress is related to poor health behaviours in COPD and non-COPD patients: evidence from the CanCOLD study
journal contributionposted on 14.11.2018, 16:27 by Nicola Paine, Simon L. Bacon, Jean Bourbeau, Wan C. Tan, Kim L. Lavoie, Shawn D. Aaron, Kenneth R. Chapman, J. Mark FitzGerald, Paul Hernandez, Darcy D. Marciniuk, Francois Maltais, Denis E. O'Donnell, Don Sin, Brandie L. Walker
Background: Patients with psychiatric disorders (depression, anxiety) are more likely to have poor health behaviours, including higher smoking and lower physical activity (PA) levels. Smoking is a major risk factor for Chronic Obstructive Pulmonary Disease (COPD), and PA is critical for COPD management. However, no studies have assessed associations between psychological distress and these behaviours among patients with vs without COPD. This is a sub-analysis of the CanCOLD study that assessed the relationships between psychological disorders (depression, anxiety) and poor health behaviours (smoking, PA). Methods: 717 COPD and 797 matched non-COPD individuals from the CanCOLD study, completed the Hospital Anxiety Depression Scale (HADS) to assess anxiety and depression. Smoking behaviour was self-reported pack-years smoking. The CHAMPS PA questionnaire determined calorific expenditure as a PA measure. Regressions determined relationships between anxiety/depression and health behaviours, adjusting for age, sex, BMI, GOLD stage and COPD status. Results: Across the whole sample, we observed relationships between depression (β=1.107 ± 0.197; 95%CI=0.691 – 1.462; p<.001) and anxiety (β=0.780 ± 0.170; 95%CI=0.446 – 1.114; p<.001) and pack years. Higher depression (β=-0.220 ± 0.028; 95%CI=-0.275 – -0.165; p<.001) and anxiety (β=-0.091 ± 0.025; 95%CI= -0.139 – -0.043; p<.001) scores were related to lower PA. These associations were comparable across COPD and non-COPD patients. Conclusions: Results showed that higher levels of anxiety and depression were related to higher cumulative smoking and lower levels of PA in patients with and without COPD, suggesting symptoms of psychological distress is similarly associated with poorer health behaviours in COPD and non-COPD individuals. Future studies need to determine if treating symptoms of psychological distress can improve health behaviours and outcomes in this population.
The Canadian Cohort Obstructive Lung Disease (CanCOLD) study is currently funded by the Canadian Respiratory Research Network; industry partners are AstraZeneca Canada Ltd., Boehringer Ingelheim Canada Ltd., GlaxoSmithKline Canada Ltd., and Novartis. Researchers at RI-MUHC Montreal and Icapture Centre Vancouver lead the project. Previous funding partners were the CIHR (CIHR/Rx&D Collaborative Research Program Operating Grants, 93326) and the Respiratory Health Network of the FRSQ; industry partners were Almirall, Merck, Nycomed, Pfizer Canada Ltd., and Theratechnologies.
- Sport, Exercise and Health Sciences